Showing results (121-130 of 132) with videos related to
Sort By:
Pageof 14
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|March 24, 2019
Updated Efficacy and Safety Data and Impact of the EML4-ALK Fusion Variant on the Efficacy of Alectinib in Untreated ALK-Positive Advanced Non-Small Cell Lung Cancer in the Global Phase III ALEX StudyD Ross Camidge, Rafal Dziadziuszko, Solange Peters, et al.Infection, Genetics and Evolution : Journal of Molecular Epidemiology and Evolutionary Genetics in Infectious Diseases|February 25, 2024
Evolution of SARS-CoV-2 in the Rhine-Neckar/Heidelberg Region 01/2021 - 07/2023Christian Bundschuh, Niklas Weidner, Julian Klein, et al.Lung Cancer (Amsterdam, Netherlands)|November 10, 2019
Pooled overall survival and safety data from the pivotal phase II studies (NP28673 and NP28761) of alectinib in ALK-positive non-small-cell lung cancerSai-Hong Ignatius Ou, Shirish M Gadgeel, Fabrice Barlesi, et al.Journal of Medical Virology|December 3, 2024
Elevated Soluble ACE2 Activity in Children and Adults After SARS-CoV-2 Exposure Irrespective of Laboratory-Confirmed InfectionMaximilian Stich, Vladimir Gonçalves Magalhães, Friederike Bürger, et al.Plos Medicine|January 23, 2025
Persistent symptoms and clinical findings in adults with post-acute sequelae of COVID-19/post-COVID-19 syndrome in the second year after acute infection: A population-based, nested case-control studyRaphael S Peter, Alexandra Nieters, Siri Göpel, et al.Bioessays : News and Reviews in Molecular, Cellular and Developmental Biology|December 30, 2020
Microscopy-based assay for semi-quantitative detection of SARS-CoV-2 specific antibodies in human sera: A semi-quantitative, high throughput, microscopy-based assay expands existing approaches to measure SARS-CoV-2 specific antibody levels in human seraConstantin Pape, Roman Remme, Adrian Wolny, et al.Ebiomedicine|September 26, 2022
Long COVID symptoms in exposed and infected children, adolescents and their parents one year after SARS-CoV-2 infection: A prospective observational cohort studyAnneke Haddad, Aleš Janda, Hanna Renk, et al.Trials|October 7, 2020
A Randomized Open label Phase-II Clinical Trial with or without Infusion of Plasma from Subjects after Convalescence of SARS-CoV-2 Infection in High-Risk Patients with Confirmed Severe SARS-CoV-2 Disease (RECOVER): A structured summary of a study protocol for a randomised controlled trialMaike Janssen, Ulrike Schäkel, Carine Djuka Fokou, et al.Emerging Infectious Diseases|October 25, 2021
Transmission of Severe Acute Respiratory Syndrome Coronavirus 2 in Households with Children, Southwest Germany, May-August 2020Maximilian Stich, Roland Elling, Hanna Renk, et al.JAMA Pediatrics|January 22, 2021
Prevalence of SARS-CoV-2 Infection in Children and Their Parents in Southwest GermanyBurkhard Tönshoff, Barbara Müller, Roland Elling, et al.Pageof 14